Dermatophyte infections

American Family Physician

Volumn 67, Issue 1, 2003, Pages 101-108

  Hainer, Barry L ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLYLAMINE DERIVATIVE; AMMONIUM LACTATE; ANTIFUNGAL AGENT; BUTENAFINE; CICLOPIROX; CICLOPIROXOLAMINE; CLOTRIMAZOLE; CORTICOSTEROID; ECONAZOLE; FLUCONAZOLE; FUNGICIDE; GRISEOFULVIN; HYDROCORTISONE ACETATE; IMIDAZOLE; ITRACONAZOLE; KETOCONAZOLE; MICONAZOLE; NAFTIFINE; OXICONAZOLE; SELENIUM SULFIDE; SULCONAZOLE; TERBINAFINE; TOLNAFTATE;

ARTICLE; CLINICAL FEATURE; CLINICAL TRIAL; COST EFFECTIVENESS ANALYSIS; DERMATOMYCOSIS; DERMATOPHYTE; DRUG CLEARANCE; DRUG COST; DRUG EFFICACY; DRUG INDICATION; FUNGUS CULTURE; FUNGUS TRANSMISSION; HISTOLOGY; HUMAN; INFECTION RISK; LABORATORY TEST; LIVER TOXICITY; META ANALYSIS; MICROSCOPY; ONYCHOMYCOSIS; PHYSICAL EXAMINATION; SKIN BIOPSY; TINEA BARBAE; TINEA CAPITIS; TINEA CORPORIS; TINEA CRURIS; TINEA FACIEI; TINEA MANUUM; TINEA PEDIS; ULTRAVIOLET RADIATION;

ANTIFUNGAL AGENTS; ARTHRODERMATACEAE; CLINICAL TRIALS; DERMATOMYCOSES; DIAGNOSIS, DIFFERENTIAL; HUMANS; HYDROXIDES; POTASSIUM COMPOUNDS;

EID: 0037284255     PISSN: 0002838X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Hirschmann JV. Fungal, bacterial, and viral infections of the skin. In: Scientific American medicine, CD-ROM. New York: Scientific American, Inc., 2001.
2. Martin AG, Koboyashi GS. Superficial fungal infection: dermatophytosis, tinea nigra, piedra. In: Freedberg IM, et al., eds. Fitzpatrick's Dermatology in general medicine. Vol. 2. 5th ed. New York: McGraw-Hill, 1999:2337-57.
3. Rosen T. Dermatophytosis: diagnostic pointers and therapeutic pitfalls. Consultant 1997;37:1545-57.
4. Abdel-Rahman SM, Nahata MC. Treatment of tinea capitis. Ann Pharmacother 1997;31:338-48.
5. Aly R. Ecology, epidemiology and diagnosis of tinea capitis. Pediatr Infect Dis J 1999;18:180-5.
6. Hubbard TW. The predictive value of symptoms in diagnosing childhood tinea capitis. Arch Pediatr Adolesc Med 1999;153:1150-3.
7. Elewski BE. Tinea capitis: a current perspective. J Am Acad Dermatol 2000;42(1 pt 1):1-20.
8. Friedlander SF. The optimal therapy for tinea capitis. Pediatr Dermatol 2000;17:325-6.
9. Elewski BE. Treatment of tinea capitis: beyond griseofulvin. J Am Acad Dermatol 1999;40(6 pt 2):S27-30.
10. Gupta AK, Hofstader SL, Adam P, Summerbell RC. Tinea capitis: an overview with emphasis on management. Pediatr Dermatol 1999;16:171-89.
11. Gupta AK, Nolting S, de Prost Y, Delescluse J, Degreef H, Theissen U, et al. The use of itraconazole to treat cutaneous fungal infections in children. Dermatology 1999;199:248-52.
12. Temple ME, Nahata MC, Koranyi KI. Pharmacotherapy of tinea capitis. J Am Board Fam Pract 1999;12:236-42.
13. Gupta AK, Adam P, Dlova N, Lynde CW, Hofstader S, Morar N, et al. Therapeutic options for the treatment of tinea capitis caused by Trichophyton species: griseofulvin versus the new oral antifungal agents, terbinafine, itraconazole, and fluconazole. Pediatr Dermatol 2001;18:433-8.
14. Higgins EM, Fuller LC, Smith CH. Guidelines for the management of tinea capitis. British Association of Dermatologists. Br J Dermatol 2000;143:53-8.
15. Givens TG, Murray MM, Baker RC. Comparison of 1% and 2.5% selenium sulfide in the treatment of tinea capitis. Arch Pediatr Adolesc Med 1995;149:808-11.
16. Evans EG, Dodman B, Williamson DM, Brown GJ, Bowen RG. Comparison of terbinafine and clotrimazole in treating tinea pedis. BMJ 1993;307:645-7.
17. Evans EG. Tinea pedis: clinical experience and efficacy of short treatment. Dermatology 1997;194(suppl 1):3-6.
18. Shear NH, Einarson TR, Arikian SR, Doyle JJ, van Assche D. Pharmacoeconomic analysis of topical treatments for tinea infections. Int J Dermatol 1998;37:64-71.
19. Noble SL, Forbes RC, Stamm PL. Diagnosis and management of common tinea infections. Am Fam Physician 1998;58:163-74, 177-8.
20. Zuber TJ, Baddam K. Superficial fungal infection of the skin. Where and how it appears help determine therapy. Postgrad Med 2001;109(1):117-20, 123-6, 131-2.
21. Goldstein AO, Smith KM, Ives TJ, Goldstein B. Mycotic infections. Effective management of conditions involving the skin, hair, and nails. Geriatrics 2000;55:40-2, 45-7,51-2.
22. Gupta AK, Jain HC, Lynde CW, Watteel GN, Summerbell RC. Prevalence and epidemiology of unsuspected onychomycosis in patients visiting dermatologists' offices in Ontario, Canada - a multicenter survey of 2,001 patients. Int J Dermatol 1997;36:783-7.
23. Rodgers P, Bassler M. Treating onychomycosis. Am Fam Physician 2001;63:663-72,677-8.
24. Lawry MA, Haneke E, Strobeck K, Martin S, Zimmer B, Romano PS. Methods for diagnosing onychomycosis: a comparative study and review of the literature. Arch Dermatol 2000;136:1112-6.
25. Mehregan DR, Gee SL. The cost effectiveness of testing for onychomycosis versus empiric treatment of onychodystrophies with oral antifungal agents. Cutis 1999;64:407-10.
26. Gupta AK, Fleckman P, Baran R. Ciclopirox nail lacquer topical solution 8% in the treatment of toe-nail onychomycosis. J Am Acad Dermatol 2000;43(4 suppl):S70-80.
27. Harrell TK, Necomb WW, Replogle WH, King DS, Noble SL. Onychomycosis: improved cure rates with itraconazole and terbinafine. J Am Board Fam Pract 2000;13:268-73.